Your Cart Is Empty!
Tuesday, 24 May 2016
A recent study presented at the American College of Rheumatology (ACR) found chondroitin was significantly superior to celecoxib ( a prescription medicine) at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients.
Researchers say this trial is the first of its kind to demonstrate the superiority of chondroitin sulfate in reducing the long-term progression of knee osteoarthritis structural changes. The study results have important implications for the long-term management of patients with knee osteoarthritis they say.
Previous studies have similarly found Omega-3 (also called ‘n-3’) polyunsaturated fatty acids help with inflammatory types of arthritis such as rheumatoid arthritis, reactive arthritis, psoriatic arthritis and ankylosing spondylitis and Osteoarthritis. Recent research shows they can help even if you're also taking strong disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate.
Many people with osteoarthritis use glucosamine and chondroitin. Joint cartilage normally contains glucosamine and chondroitin compounds, and studies show that taking supplements of these natural ingredients helps improve the health of damaged cartilage. The recommended level of Glucosamine is 1500mg (exactly the dose in Sona JointPlan).